NTI

2.78%

7.0¢ neurotech international limited

Many thanks mate for sharing your thoughts on this.

First 51 Last

Share
Profile

Follow
ma420

6,633 Posts.

1670

17/04/24

12:03

Post #: 73385241
Share

Originally posted by Scrooge1: ↑

Nothing wrong with raising cash for a biotech like NTI and I agree, the discount is actually rather small when compared to many other cap raises. The disappointment lies in the exceptionally poor timing.
With announcements like today which don't come very often, one would expect a very significant rise in the share price. Hold off the CR for a couple of weeks and the vwap would be much higher thus limiting the dilution. The company may have been valued at 50% more when the raise would be done meaning that its not 10% equity and 10% dilution but significantly less.
Additionally, the CR indicates the price at which management rate the company at and like I said above, if you sell the company's shares for 10 cents, no-one in their right mind will pay significantly more.
Management have anchored the SP in the mind of investors at 10c for at least the near future which was a time when there otherwise was the prospect of significant growth due to the significant progress that was achieved.
Management are to be congratulated for running two successful trials, but their business acumen is either lacking or like Tony above states, they have done a pretty deal for mates leaving retail holders out of the equation and eroding their potential profits.

Expand

Many thanks mate for sharing your thoughts on this.

NTI Price at posting: 10.8¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

RCE

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

There are more pages in this discussion • 36 more messages in this thread...

First 51 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change -0.002(2.78%)		Mkt cap ! $71.21M

Open	High	Low	Value	Volume
7.3¢	7.3¢	7.0¢	$86.59K	1.228M

Buyers (Bids)

No.	Vol.	Price($)
1	6000	7.1¢

Sellers (Offers)

Price($)	Vol.	No.
7.5¢	72226	1

View Market Depth

No.	Vol.	Price($)
2	138838	0.070
2	62535	0.069
1	973610	0.068
2	159208	0.067
1	150000	0.066

Price($)	Vol.	No.
0.075	72226	1
0.076	100000	1
0.077	116800	2
0.078	94680	3
0.079	300000	1

Last trade - 15.38pm 28/06/2024 (20 minute delay)

NTI (ASX) Chart

Many thanks mate for sharing your thoughts on this.

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Many thanks mate for sharing your thoughts on this.

Top Stories

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News